Skip to content

Clinical trials

Thyroid Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Clear all

719 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20014
20023
20037
200419
200512
200617
200714
200822
200916
201024
201122
201225
201323
201424
201523
201630
201736
201839
201924
202045
202136
202260
202339
202442
202551
202633

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed309
Recruiting126
Unknown status121
Active, not recruiting60
Terminated47
Not yet recruiting30
Withdrawn16
Enrolling by invitation5
Approved for marketing2
No longer available1
Suspended1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)41
Memorial Sloan Kettering Cancer Center23
Fujian Medical University16
Fudan University15
M.D. Anderson Cancer Center15
Yonsei University11
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8
National Taiwan University Hospital8
Assiut University7
Eli Lilly and Company7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms719
Thyroid Cancer, Papillary81
Thyroid Nodule68
Breast Neoplasms67
Head and Neck Neoplasms60
Neoplasms52
Melanoma51
Carcinoma, Medullary49
Thyroid Diseases49
Adenocarcinoma, Follicular48

Trials

Showing 51 to 75 of 719. Each trial links to its page on Pharma Observatory.

619 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.